Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 17 | 2025 | 1232 | 2.480 |
Why?
|
| Adipose Tissue, Brown | 11 | 2025 | 118 | 2.310 |
Why?
|
| Hypothalamus | 12 | 2024 | 132 | 2.290 |
Why?
|
| Thermogenesis | 8 | 2025 | 121 | 2.010 |
Why?
|
| Eating | 7 | 2020 | 138 | 1.750 |
Why?
|
| Natriuretic Peptides | 3 | 2019 | 9 | 1.700 |
Why?
|
| Receptors, Opioid, kappa | 5 | 2024 | 8 | 1.400 |
Why?
|
| Signal Transduction | 7 | 2024 | 3034 | 1.150 |
Why?
|
| Leptin | 5 | 2024 | 85 | 0.970 |
Why?
|
| Interleukin-15 | 1 | 2024 | 25 | 0.880 |
Why?
|
| Body Weight | 5 | 2024 | 377 | 0.880 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 32 | 0.860 |
Why?
|
| Energy Metabolism | 9 | 2024 | 379 | 0.820 |
Why?
|
| Sulfonamides | 1 | 2024 | 127 | 0.800 |
Why?
|
| Narcotic Antagonists | 2 | 2024 | 136 | 0.780 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 738 | 0.770 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2017 | 15 | 0.660 |
Why?
|
| Guanylyl Cyclase C Agonists | 1 | 2020 | 1 | 0.660 |
Why?
|
| Receptors, Enterotoxin | 1 | 2020 | 6 | 0.660 |
Why?
|
| Animals | 35 | 2025 | 20622 | 0.660 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 92 | 0.650 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 121 | 0.620 |
Why?
|
| Rats | 12 | 2024 | 1977 | 0.600 |
Why?
|
| Dopamine | 1 | 2019 | 105 | 0.600 |
Why?
|
| Mice | 23 | 2025 | 10816 | 0.590 |
Why?
|
| Puberty | 1 | 2018 | 59 | 0.580 |
Why?
|
| Weight Gain | 4 | 2023 | 169 | 0.570 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2017 | 4 | 0.560 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 424 | 0.550 |
Why?
|
| Exercise | 1 | 2024 | 940 | 0.530 |
Why?
|
| Peptides | 1 | 2020 | 574 | 0.500 |
Why?
|
| Diet | 4 | 2024 | 524 | 0.490 |
Why?
|
| Liver | 6 | 2024 | 851 | 0.460 |
Why?
|
| Mice, Knockout | 8 | 2025 | 2107 | 0.430 |
Why?
|
| Hypothalamic Hormones | 3 | 2019 | 4 | 0.430 |
Why?
|
| Pituitary Hormones | 3 | 2019 | 7 | 0.430 |
Why?
|
| Melanins | 3 | 2019 | 24 | 0.430 |
Why?
|
| Adipose Tissue, White | 4 | 2024 | 87 | 0.430 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 1184 | 0.430 |
Why?
|
| Male | 26 | 2025 | 29821 | 0.420 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 245 | 0.420 |
Why?
|
| Adiposity | 3 | 2019 | 83 | 0.410 |
Why?
|
| Ependymoglial Cells | 2 | 2024 | 3 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 12 | 2025 | 3388 | 0.410 |
Why?
|
| Gastric Mucosa | 4 | 2017 | 53 | 0.390 |
Why?
|
| Brain | 3 | 2022 | 1554 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2019 | 619 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 226 | 0.380 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 149 | 0.380 |
Why?
|
| Sirtuin 1 | 2 | 2022 | 26 | 0.350 |
Why?
|
| Ghrelin | 4 | 2016 | 18 | 0.340 |
Why?
|
| Receptors, Dopamine | 2 | 2024 | 16 | 0.320 |
Why?
|
| Homeostasis | 3 | 2024 | 370 | 0.320 |
Why?
|
| Uncoupling Protein 1 | 3 | 2025 | 49 | 0.310 |
Why?
|
| Fibroblast Growth Factors | 3 | 2024 | 72 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2020 | 82 | 0.300 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2024 | 13 | 0.270 |
Why?
|
| Weight Loss | 3 | 2024 | 272 | 0.260 |
Why?
|
| Nutritional Status | 3 | 2016 | 98 | 0.250 |
Why?
|
| Phosphorylation | 4 | 2024 | 937 | 0.240 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2023 | 85 | 0.240 |
Why?
|
| Oxyntomodulin | 1 | 2024 | 2 | 0.230 |
Why?
|
| Caveolae | 1 | 2024 | 2 | 0.230 |
Why?
|
| Caveolin 1 | 1 | 2024 | 8 | 0.230 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2024 | 13 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2024 | 10 | 0.230 |
Why?
|
| Pancreas | 2 | 2024 | 150 | 0.230 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2024 | 34 | 0.220 |
Why?
|
| Muscle Strength | 1 | 2024 | 40 | 0.220 |
Why?
|
| Diet, High-Fat | 3 | 2020 | 174 | 0.220 |
Why?
|
| Dopamine Agonists | 1 | 2024 | 22 | 0.220 |
Why?
|
| Rodentia | 1 | 2024 | 22 | 0.210 |
Why?
|
| Mitochondrial Proteins | 1 | 2025 | 102 | 0.210 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 60 | 0.210 |
Why?
|
| Locomotion | 1 | 2024 | 116 | 0.210 |
Why?
|
| Estrogens | 1 | 2024 | 116 | 0.210 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2019 | 7 | 0.200 |
Why?
|
| Hepatocytes | 2 | 2020 | 217 | 0.190 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2022 | 4 | 0.190 |
Why?
|
| Adipocytes | 1 | 2024 | 268 | 0.190 |
Why?
|
| Cell Membrane | 1 | 2024 | 494 | 0.190 |
Why?
|
| Fatty Liver | 1 | 2023 | 107 | 0.190 |
Why?
|
| Malaria, Cerebral | 1 | 2022 | 23 | 0.190 |
Why?
|
| Hypothyroidism | 1 | 2022 | 43 | 0.190 |
Why?
|
| Injections, Intraventricular | 2 | 2019 | 21 | 0.190 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 13 | 0.180 |
Why?
|
| Glucose Intolerance | 2 | 2019 | 90 | 0.180 |
Why?
|
| Glucose | 1 | 2024 | 467 | 0.180 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2017 | 10 | 0.180 |
Why?
|
| Receptors, Cannabinoid | 1 | 2020 | 7 | 0.170 |
Why?
|
| Lysophospholipids | 1 | 2020 | 27 | 0.170 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 47 | 0.170 |
Why?
|
| ErbB Receptors | 1 | 2021 | 114 | 0.170 |
Why?
|
| Insulin Resistance | 2 | 2022 | 410 | 0.170 |
Why?
|
| Cardiomegaly | 1 | 2020 | 34 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 143 | 0.170 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 31 | 0.170 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 23 | 0.170 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 53 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2020 | 45 | 0.170 |
Why?
|
| Breast Feeding | 1 | 2022 | 149 | 0.160 |
Why?
|
| Piperidines | 2 | 2017 | 63 | 0.160 |
Why?
|
| Bromocriptine | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hyperphagia | 1 | 2019 | 18 | 0.160 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 220 | 0.160 |
Why?
|
| Pyrazoles | 2 | 2017 | 78 | 0.160 |
Why?
|
| Humans | 15 | 2025 | 63293 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 86 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 152 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 14 | 0.160 |
Why?
|
| Female | 11 | 2025 | 32791 | 0.150 |
Why?
|
| Mice, Obese | 1 | 2019 | 80 | 0.150 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 14 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 70 | 0.150 |
Why?
|
| Myocardium | 1 | 2020 | 274 | 0.150 |
Why?
|
| Nicotine | 1 | 2019 | 117 | 0.150 |
Why?
|
| Sexual Maturation | 1 | 2018 | 51 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2019 | 864 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 21 | 0.140 |
Why?
|
| Behavior, Animal | 1 | 2020 | 230 | 0.140 |
Why?
|
| Neutrophils | 1 | 2020 | 376 | 0.140 |
Why?
|
| Morpholines | 1 | 2017 | 89 | 0.130 |
Why?
|
| Sirolimus | 1 | 2017 | 92 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 203 | 0.130 |
Why?
|
| Lipids | 1 | 2019 | 314 | 0.130 |
Why?
|
| Models, Animal | 1 | 2017 | 236 | 0.130 |
Why?
|
| Neurons | 2 | 2019 | 922 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 451 | 0.130 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 44 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 304 | 0.130 |
Why?
|
| Splanchnic Circulation | 1 | 2016 | 16 | 0.120 |
Why?
|
| Growth Hormone | 1 | 2016 | 18 | 0.120 |
Why?
|
| Autonomic Pathways | 1 | 2015 | 2 | 0.120 |
Why?
|
| Efferent Pathways | 1 | 2015 | 13 | 0.120 |
Why?
|
| Defecation | 1 | 2015 | 17 | 0.120 |
Why?
|
| Vagus Nerve | 1 | 2015 | 21 | 0.120 |
Why?
|
| Fibronectins | 1 | 2015 | 43 | 0.120 |
Why?
|
| Sympathetic Nervous System | 1 | 2015 | 35 | 0.120 |
Why?
|
| Peptide Hormones | 1 | 2015 | 8 | 0.120 |
Why?
|
| Anorexia Nervosa | 1 | 2015 | 16 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2016 | 155 | 0.110 |
Why?
|
| Fasting | 1 | 2015 | 51 | 0.110 |
Why?
|
| Lactation | 1 | 2015 | 69 | 0.110 |
Why?
|
| Testosterone | 1 | 2015 | 121 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 98 | 0.110 |
Why?
|
| Proteome | 1 | 2015 | 149 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1617 | 0.110 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Adolescent | 3 | 2019 | 6241 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 27 | 0.100 |
Why?
|
| Heart Failure | 1 | 2020 | 915 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2015 | 295 | 0.100 |
Why?
|
| Child | 2 | 2019 | 4525 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 259 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1537 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 695 | 0.090 |
Why?
|
| Inflammation | 3 | 2023 | 1145 | 0.080 |
Why?
|
| Agouti-Related Protein | 2 | 2018 | 6 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1255 | 0.060 |
Why?
|
| Adiponectin | 1 | 2024 | 36 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2024 | 56 | 0.060 |
Why?
|
| Cannabinoids | 2 | 2016 | 41 | 0.060 |
Why?
|
| Lipid Droplets | 1 | 2024 | 33 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2024 | 47 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2179 | 0.050 |
Why?
|
| Fatty Acid Synthases | 1 | 2023 | 24 | 0.050 |
Why?
|
| Estradiol | 1 | 2024 | 257 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 284 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2013 | 127 | 0.050 |
Why?
|
| Plasmodium berghei | 1 | 2022 | 21 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 2569 | 0.050 |
Why?
|
| Adult | 4 | 2020 | 16786 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 371 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 17551 | 0.040 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2020 | 8 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 17 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Cognition | 1 | 2024 | 483 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 24 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 67 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2020 | 139 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2020 | 34 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 201 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2020 | 68 | 0.040 |
Why?
|
| Regeneration | 1 | 2020 | 94 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 190 | 0.040 |
Why?
|
| Ganglionic Stimulants | 1 | 2019 | 6 | 0.040 |
Why?
|
| Ideal Body Weight | 1 | 2019 | 1 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 373 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 130 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 187 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 444 | 0.040 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 110 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 45 | 0.040 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2017 | 6 | 0.040 |
Why?
|
| Appetite Depressants | 1 | 2017 | 6 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 369 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1275 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 382 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2036 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 538 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2151 | 0.030 |
Why?
|
| Angiopoietin-like Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Body Composition | 1 | 2015 | 152 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 985 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2569 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 197 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1989 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 11 | 0.030 |
Why?
|
| Drug Administration Routes | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1348 | 0.030 |
Why?
|
| Receptors, Ghrelin | 1 | 2013 | 2 | 0.030 |
Why?
|
| Orexins | 1 | 2013 | 6 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2013 | 26 | 0.030 |
Why?
|
| Reinforcement Schedule | 1 | 2013 | 8 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 13 | 0.030 |
Why?
|
| Infusions, Intraventricular | 1 | 2013 | 12 | 0.030 |
Why?
|
| Enkephalins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Taste | 1 | 2013 | 36 | 0.030 |
Why?
|
| Microinjections | 1 | 2013 | 69 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2015 | 483 | 0.020 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 37 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2013 | 83 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2013 | 82 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 608 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 893 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 686 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 860 | 0.020 |
Why?
|
| Dependovirus | 1 | 2017 | 709 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1558 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 337 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 839 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 346 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 398 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5655 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3761 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4686 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 14392 | 0.010 |
Why?
|